Why the study?
Does coronary angioplasty with high-dose heparin and aspirin cause early intracoronary hemostatic activation in patients with stable angina?
Does coronary angioplasty with high-dose heparin and aspirin cause early intracoronary hemostatic activation in patients with stable angina?
Intracoronary hemostatic activation does not occur during and immediately following coronary angioplasty when high doses of heparin and aspirin are administered.
Answers are grounded in this paper and cite their sources.
Reinforces safety of high-dose heparin/aspirin during angioplasty in stable angina; leaves open effects in other populations or regimens.
To characterize the extent of early activation of the hemostatic system following angioplasty, we obtained blood samples from the involved coronary artery of 11 stable angina patients during the procedure and measured sensitive markers of thrombin formation (fibrinopeptide A, prothrombin fragment 1.2, and soluble fibrin) and of platelet activation (beta-thromboglobulin). Levels of hemostatic markers in venous blood obtained from 14 young individuals with low pretest probability for coronary artery disease were not significantly different from levels in venous blood or intracoronary samples obtained prior to angioplasty. Also, there was no translesional (proximal and distal to the lesion) gradient in any of the hemostatic markers before or after angioplasty in samples obtained between 18 and 21 min from the onset of the first balloon inflation. Furthermore, no significant difference was noted between angioplasty and postangioplasty intracoronary concentrations. We conclude that intracoronary hemostatic activation does not occur in the majority of patients during and immediately following coronary angioplasty when high doses of heparin and aspirin are administered.
No takes yet. Share an insight, caveat, or question.
Shammas et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: